MultiKano is the first automatic cell type annotation method tailored to single-cell multi-omics data. MultiKano introduces a novel data augmentation strategy based on paired scRNA-seq and scATAC ...

The Cross-Species Cell Atlas: Chan Zuckerberg Initiative Releases TranscriptFormer AI Model Trained on single-cell transcriptomics data covering 1.5 billion years of evolution, CZI’s new ...

"Not all cells in a tumor are cancer cells -- they're not even always the most dominant cell type," said Sylvia Plevritis, PhD, chair of Stanford Medicine's department of biomedical data science.

Sana Biotechnology will present clinical data on UP421, a hypoimmune islet cell therapy for type 1 diabetes, at an upcoming symposium.

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of ...

About Type 1 Diabetes T1D results from the autoimmune destruction of insulin-producing beta cells in pancreatic islets.

Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature ...

Data were derived from Rickels MR, et al. Improvement in glycemic control and elimination of exogenous insulin use in patients with type 1 diabetes infused with fully differentiated islet cells ...

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...

Sana Biotechnology reports six-month results from a first-in-human study demonstrating safe pancreatic islet cell transplantation for type 1 diabetes without immunosuppression.